Does Mounjaro Cause Hair Loss? Clinical Evidence & Risk Factors

Last reviewed: May 17, 2026

Last updated: May 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Hair loss during Mounjaro (tirzepatide) therapy has been reported by some patients, though clinical trial data did not identify alopecia as a primary adverse event. The phenomenon may relate to rapid weight loss, nutritional depletion, or metabolic stress rather than direct drug toxicity.

For individuals considering GLP-1 medications, understanding your baseline health status, nutrient levels, and genetic predispositions can support a more informed conversation with your provider. PlexusDx takes a precision-wellness approach—using available clinical context and genetic insights to help you anticipate potential side effects and plan accordingly.

What Clinical Trials Actually Reported About Hair Loss

Mounjaro's pivotal clinical trials (SURMOUNT series) tracked safety outcomes across thousands of participants. Hair loss was not listed as a common or serious adverse event in the package insert or regulatory submissions.

However, post-market reports and patient forums document hair shedding during GLP-1 therapy. This gap between trial data and real-world reports suggests the phenomenon may be underdetected, rare enough to miss statistical significance, or context-dependent on patient factors like diet, stress, and baseline nutrient status.

Three Proposed Mechanisms: Rapid Weight Loss, Nutritional Shifts, and Metabolism

Hair loss during weight loss is well-established in dermatology. Rapid calorie deficit activates telogen effluvium—a temporary shedding phase—affecting 30-50% of hair follicles. GLP-1 drugs can accelerate weight loss, potentially triggering this response in susceptible individuals.

The comparison framework below outlines three leading hypotheses for GLP-1-associated hair loss and the clinical evidence supporting each mechanism.

Proposed Mechanism	Evidence & Clinical Relevance
Telogen Effluvium from Rapid Weight Loss	Documented in 20-30% of patients losing >5-10% body weight over 3 months; reversible but takes 3-6 months to resolve after stabilization
Nutritional Depletion (Iron, Zinc, B12, Protein)	GLP-1s reduce appetite and food intake; studies show micronutrient gaps in rapid-loss populations; supplementation may reduce shedding
Metabolic Shift & Thyroid Sensitivity	Weight loss alters thyroid hormone dynamics; some patients develop subclinical hypothyroidism; genetic variants in thyroid pathways may increase vulnerability
Direct Drug Effect (Less Likely)	No biologically plausible mechanism identified; GLP-1R not abundant in hair follicles; adverse event rate does not exceed placebo in trials

Risk Factors That May Increase Your Likelihood of Hair Loss

Not all patients on Mounjaro experience hair loss. Individual factors—baseline nutrition, genetics, rate of weight loss, age, and hormonal status—shape your risk profile. Women, those with a family history of hair thinning, and individuals with pre-existing nutritional gaps are often more vulnerable.

Rapidly reaching high doses, losing more than 15-20% body weight in 3-4 months, or skipping nutritional support during therapy may amplify telogen effluvium. Conversely, gradual titration, adequate protein, iron, zinc, and biotin intake, and stress management can mitigate risk.

How to Monitor and Manage Hair Loss Risk Before and During Therapy

Before starting Mounjaro or any GLP-1 medication, establish a baseline: assess ferritin, zinc, vitamin B12, and thyroid function with your provider. These biomarkers inform your nutritional strategy and may predict your susceptibility to metabolic stress-induced hair loss.

During therapy, pace your dosage increase, maintain high-protein intake (1.2-1.6 g/kg body weight), and consider prophylactic supplementation with iron, biotin, and zinc if baseline levels are low. Monitor your hair fall pattern and discuss any increase with your provider—early intervention with nutrition or dose adjustment can often arrest progression.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test examines variants in peptide-related pathways—including FTO, MC4R, GLP1R, and GIPR—that influence your metabolic response to GLP-1 therapy. While the test does not directly predict hair loss, it may help provide context for how your body processes weight loss and responds to metabolic stress, informing your preventive strategy.

The test reveals predispositions in genetic pathways governing appetite regulation, energy expenditure, and nutrient sensitivity. Patients with certain FTO or MC4R variants, for example, may experience faster metabolic shifts during GLP-1 treatment. This information should be interpreted with a qualified healthcare provider to shape your nutritional and dosing plan.

Understanding your genetic context can support a more personalized conversation with your provider about pacing therapy, baseline nutrient testing, and supplementation strategy. Combined with clinical assessment of your weight loss rate and nutritional status, genetic insights help you anticipate and mitigate potential side effects like hair loss before they become significant.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is hair loss a guaranteed side effect of Mounjaro?

No. Hair loss is not a listed adverse event in clinical trials and does not occur in most Mounjaro users. It appears to be context-dependent, linked more to rapid weight loss and nutritional factors than to the medication itself.

How long does GLP-1-related hair loss typically last?

If hair loss is due to telogen effluvium from rapid weight loss, shedding usually peaks 2-4 months after weight stabilizes and resolves within 3-6 months with adequate nutrition and lower stress. If it persists beyond 6 months, other causes should be evaluated.

What baseline tests should I get before starting Mounjaro to assess hair loss risk?

Ask your provider to check ferritin, serum iron, zinc, vitamin B12, folate, and thyroid function (TSH, free T4). Low levels in any of these predict higher risk for stress-related shedding during rapid weight loss.

Can I prevent hair loss while taking Mounjaro?

Yes. Maintain adequate protein (1.2-1.6 g/kg), consider biotin, iron, and zinc supplementation if baseline levels are low, pace your dose increases, and manage stress. Gradual weight loss reduces telogen effluvium risk significantly.

Does the PlexusDx Precision Peptide Genetic Test predict if I'll lose hair on Mounjaro?

No. The test predicts predispositions in peptide metabolism and weight loss response, not exact side effects. However, results can inform your provider's nutritional and dosing strategy to mitigate metabolic stress—a major driver of hair shedding.

Does Mounjaro Cause Hair Loss: What the Evidence Shows and How to Assess Your Risk